Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Metabolife

This article was originally published in The Tan Sheet

Executive Summary

FSI drops Jan. 28 for ready-to-drink shakes and bars extending the popular Metabolife 356 weight loss line. One coupon offers two free bars with the purchase of the flagship product. Packaging for product line features a banner reading: "Metabolife. America's Choice for Weight Loss" and notes the shakes "Help energize your diet." New multi-million dollar ad campaign accompanying launch began Dec. 26 (1"The Tan Sheet" Jan. 1, p. 5)

You may also be interested in...



Metabolife Line Extensions' Launch Date Targets Prime Dieting Season

Metabolife International plans to support its mass market launch of "stimulant free" meal replacement shakes and diet and energy bars with a multi-million dollar TV, radio and print ad campaign slated to begin Dec. 26.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel